Professor Kate Seib is a NHMRC Leadership Fellow and the Associate Director (Research) at the Institute for Glycomics, Griffith University. Prof Seib's expertise is in the field of molecular microbiology, with a focus on characterising virulence mechanisms and developing vaccines for human mucosal pathogens including Neisseria gonorrhoeae.

Prof Seib’s work includes the discovery, pre-clinical characterisation and clinical evaluation of gonococcal vaccine candidates, as well as the use of mathematical modelling to assess the potential impact of vaccines on gonococcal prevalence. While at Novartis Vaccines she was part of the team that developed the outer membrane vesicle-based Neisseria meningitidis vaccine, 4CMenB. She is now leading two clinical trials to evaluate the ability of 4CMenB to prevent gonorrhoea.